| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Karin E. Bornfeldt | Q87887672 |
| P2093 | author name string | Alan Chait | |
| P2860 | cites work | Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 |
| Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice | Q24530027 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
| Effects of intensive glucose lowering in type 2 diabetes | Q29547736 | ||
| The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
| Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) | Q33764951 | ||
| Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway | Q34229420 | ||
| Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials | Q34601330 | ||
| Scavenger receptors that recognize advanced glycation end products | Q34871996 | ||
| Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to cholesterol metabolism | Q35079451 | ||
| The metabolic syndrome: more than the sum of its parts? | Q35546619 | ||
| The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. III. The mechanism of the inhibition of experimental cholesterol atherosclerosis in alloxan-diabetic rabbits | Q36261543 | ||
| Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? | Q36775094 | ||
| Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. | Q36883079 | ||
| Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). | Q36928042 | ||
| Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies | Q37172727 | ||
| High glucose induces IL-1beta expression in human monocytes: mechanistic insights | Q37176774 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. | Q38309468 | ||
| Atherosclerosis and insulin in primates with diabetes mellitus | Q39835559 | ||
| Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha | Q40701120 | ||
| Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
| Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Role of GSK3beta | Q43596041 | ||
| Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin | Q43606088 | ||
| Diabetes-induced accelerated atherosclerosis in swine | Q43651836 | ||
| Human arterial smooth muscle cells rapidly deplete cell culture media of glucose | Q43694766 | ||
| Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile | Q44168286 | ||
| NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older | Q44418730 | ||
| Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study | Q44680472 | ||
| Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice | Q45120387 | ||
| The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. | Q50587712 | ||
| Long-term follow-up after tight control of blood pressure in type 2 diabetes. | Q51122414 | ||
| Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? | Q51615482 | ||
| Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial | Q72198055 | ||
| Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells | Q79348211 | ||
| P921 | main subject | atherosclerosis | Q12252367 |
| hyperglycemia | Q271993 | ||
| P304 | page(s) | S335-9 | |
| P577 | publication date | 2008-11-23 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | Diabetes and atherosclerosis: is there a role for hyperglycemia? | |
| P478 | volume | 50 Suppl |
| Q36153690 | 1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis |
| Q35415550 | Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process. |
| Q35852679 | Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice |
| Q35903298 | Animal models of atherosclerosis |
| Q46568863 | Antihyperglycemia and Antihyperlipidemia Effect of Protoberberine Alkaloids From Rhizoma Coptidis in HepG2 Cell and Diabetic KK-Ay Mice |
| Q38785900 | Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial |
| Q38005031 | Cardiovascular disease risk in young people with type 1 diabetes. |
| Q37845224 | Cardiovascular function/dysfunction in adolescents with type 1 diabetes. |
| Q34523776 | Comparison of carotid and lower limb atherosclerotic lesions in both previously known and newly diagnosed type 2 diabetes mellitus |
| Q36658372 | Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammation |
| Q34399952 | Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice |
| Q89030137 | Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases |
| Q36760787 | Endovascular versus medical therapy for atherosclerotic renovascular disease |
| Q36942187 | Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases. |
| Q34501763 | Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors |
| Q60044940 | GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data |
| Q37338605 | Genotypic and phenotypic heterogeneity in Streptococcus mutans isolated from diabetic patients in Rome, Italy |
| Q91559781 | Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice |
| Q30845405 | Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review |
| Q27024469 | Glycemic control and cardiovascular disease: what's a doctor to do? |
| Q58122681 | Increased Expression of Resistin in MicroRNA-155-Deficient White Adipose Tissues May Be a Possible Driver of Metabolically Healthy Obesity Transition to Classical Obesity |
| Q91795685 | Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes |
| Q36955142 | Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway |
| Q99578648 | Inhibition of Notch Signaling Alleviated Diabetic Macrovasculopathy in an In Vitro Model |
| Q35603190 | Intermittent high glucose implements stress-induced senescence in human vascular endothelial cells: role of superoxide production by NADPH oxidase |
| Q45398280 | Isolated post-challenge hyperglycaemia and risk of cardiovascular events: Tehran Lipid and Glucose Study |
| Q35750322 | LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2. |
| Q37432907 | Long-term effects intensive medical therapy on the development and progression of subclinical atherosclerosis and the metabolic syndrome in Chinese patients with type 2 diabetes mellitus. |
| Q40050071 | Longitudinal Change in Fasting Blood Glucose and Myocardial Infarction Risk in a Population Without Diabetes |
| Q38834990 | Medical Therapy in Peripheral Artery Disease and Critical Limb Ischemia |
| Q92664771 | Metabolic influence on macrophage polarization and pathogenesis |
| Q93011588 | Metformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao Mice |
| Q26782445 | Molecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 Diabetes |
| Q89967822 | Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes |
| Q90416246 | Nonalcoholic Fatty Liver Disease |
| Q42835376 | Pharmacological effects of the water fraction of key components in the traditional Chinese prescription Mai Tong Fang on 3T3-L1 adipocytes and ob/ob diabetic mice |
| Q38628797 | Potential therapeutic effects of mTOR inhibition in atherosclerosis. |
| Q40684687 | Relation between anti-atherosclerotic effects of IRAK4 and modulation of vascular smooth muscle cell phenotype in diabetic rats |
| Q35757573 | Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice. |
| Q46305214 | Resveratrol attenuates high glucose-induced endothelial cell apoptosis via mediation of store-operated calcium entry |
| Q38181177 | Retinoid X receptor ligands: a patent review (2007 - 2013). |
| Q46267252 | Role of protein carbonylation in diabetes |
| Q44926429 | Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI. |
| Q33872769 | The Predictive Role of Tooth Extractions, Oral Infections, and hs-C-Reactive Protein for Mortality in Individuals with and without Diabetes: A Prospective Cohort Study of a 12 1/2-Year Follow-Up |
| Q55416114 | The Role of Advanced Glycation End Products in Diabetic Vascular Complications. |
| Q35119269 | The flavonols quercetin and 3',4'-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes |
| Q37106132 | The relationship between HbA₁c and ultrasound plaque textures in atherosclerotic patients |
| Q37954396 | Toll-like receptors and diabetes: a therapeutic perspective |
| Q54968435 | Vitamin D3 Induces Gene Expression of Ox-LDL Scavenger Receptors in Streptozotocin-Induced Diabetic Rat Aortas: New Insight into the Role of Vitamin D in Diabetic Atherosclerosis. |
Search more.